Cipher Surgical Ltd.

Cipher Surgical Ltd. They develop and commercialize innovative products that ensure uncompromised surgical vision. Their flagship product, the OpClear® platform, was introduced in 2013 and offers protection to the laparoscope's lens by preventing condensation and removing visual obstructions through intelligent CO2 flow and saline lens wash.

This enables procedures to continue with minimal disruption. Cipher Surgical is dedicated to research and development, investing a significant portion of their expenditure annually. They conduct clinical research to validate the impact of the OpClear platform on patient outcomes, enabling healthcare professionals to make evidence-based decisions.

Their goal is to establish in-situ lens cleaning as the standard of care by scientifically demonstrating its true value to healthcare systems worldwide. The company has achieved several significant milestones, including patents in the UK and Europe, ISO 13485 certification, CE marking, and FDA regulatory clearances. They have received positive feedback from healthcare experts, who have noted the device's ability to reduce the need for manual lens cleaning, improve surgical acuity, and streamline operative duration.

To learn more about the OpClear platform or to explore partnership opportunities, interested individuals and organizations can contact Cipher Surgical through their website or by phone